Is SandboxAQ profitable in 2026?

No public evidence of profitability exists. The Information reported Q1 2025 revenue of about 10 million dollars, with roughly 90 percent tied to a single Sergey Brin foundation contract, not diversified commercial sales, as of July 2025.

SandboxAQ is privately held, spun out of Alphabet in March 2022. Google/Alphabet remains an investor alongside Nvidia, BNP Paribas, Ray Dalio's firm, and others from its April 2025 Series E round that valued it near 5.6 to 5.78 billion dollars.

Could AI replace SandboxAQ's technology?

SandboxAQ argues generic large language models cannot replace its physics-grounded Large Quantitative Models for molecular simulation or cryptographic risk detection, but it open-sourced its flagship 5.2 million molecule dataset in June 2025, weakening its own proprietary-data claim.

Who is SandboxAQ's biggest competitor?

In cybersecurity/post-quantum cryptography, named rivals include Quantinuum, PQShield, QuSecure, ISARA, and Post-Quantum, per a May 2026 industry ranking. In drug discovery, Alphabet's own Isomorphic Labs is a direct competitive threat.

How much is SandboxAQ worth?

Reuters-confirmed private valuation is 5.6 to 5.78 billion dollars as of the April 2025 Series E round. Some aggregators like Caplight claim a post-CHIPS valuation as high as 15.64 billion dollars, but this figure is unconfirmed by press reporting.

Did SandboxAQ get government funding?

Yes. On June 17, 2026, the U.S. Department of Commerce awarded SandboxAQ a 500 million dollar CHIPS Act R&D grant, with an unusual condition attaching a minority, non-voting government equity stake to the company.

United States · United States

SandboxAQ

Alphabet spinout building physics-grounded AI models for cyber, drug discovery, materials, and navigation.

Losing its protection

Assessed 29 July 2026 · Evidence as of 29 July 2026

The structural protection is eroding.

On the recordSince 29 July 2026 · Checkable from year-end 2026 · Every call on the record Checkpoint: Full-year 2026 revenue disclosure showing whether commercial revenue diversifies beyond the Brin foundation contract

The call

A $5.6B valuation rests on defense contracts and physics-model promise, while commercial revenue outside one founder-linked deal has yet to show up.

SandboxAQ builds artificial intelligence tools designed to solve hard physics problems like discovering new drugs, creating better materials, and securing computer networks. The company is difficult to copy because its AI models are built on real physics principles rather than just patterns in text, and it has strong relationships with the U.S. Department of Defense. However, almost all of its money in early 2025 came from a single foundation grant rather than from customers paying to use the product, and the company is spread too thin across four different industries with only 300 people. The biggest threat comes from Alphabet, which both invested in SandboxAQ and also runs its own competing physics AI company called Isomorphic Labs, plus companies like CrowdStrike are moving in on the cybersecurity piece. The one thing that matters: does SandboxAQ sign up real paying customers across multiple industries by the end of 2026, or does it stay dependent on government money? Without that shift, the $5.6 billion price tag will not hold.

Why

AI pressure: Isomorphic Labs (Alphabet). Alphabet's own drug-discovery AI lab competes directly with SandboxAQ's physics models, and Alphabet also invests in and hosts SandboxAQ on Google Cloud. Could AI do the core job? Only partly.

Bigger players: CrowdStrike and Palo Alto Networks. AQtive Guard plugs into CrowdStrike Falcon and Palo Alto Networks today, but those giants could absorb the data-integration work SandboxAQ now provides. Could a giant copy it? Probably.

What protects it. FedRAMP Ready status, DoD relationships, and a $500M CHIPS Act award with government equity give it defense-market access rivals lack.

What would change this call

Whether SandboxAQ reports diversified commercial revenue above $50M ARR by end of 2026 not tied to the Brin foundation contract. Would show real enterprise traction rather than founder-adjacent funding disguised as revenue.
Whether the $500M CHIPS Act award's government equity stake survives GAO or legal review within 6 months. Would show whether the unusual funding structure is durable or challengeable.
Whether Alphabet folds SandboxAQ's physics-AI drug discovery work into Isomorphic Labs or issues competing products. Would show whether Alphabet treats SandboxAQ as a partner or a discarded internal rival.

Key numbers

Q1 2025 revenue ~$10M, ~90% from one Brin-linked contract (2025-07-16)
Valuation $5.6B to $5.78B after Series E (2025-04-01)
$500M CHIPS Act award with Commerce equity stake (2026-06-17)

Named risks

Revenue concentration in one Brin-linked contract undermines the commercial-traction story behind the 5.6 billion dollar valuation. Severity: high
CHIPS Act award's unusual government equity structure could face legal or GAO challenge. Severity: medium
Open-sourced 5.2 million molecule dataset weakens the proprietary-data moat against competitors. Severity: medium
Product line spread across four industries at roughly 300 employees dilutes focus versus dominant incumbents. Severity: medium
Secondary-market share price swung about 44 percent in six months, signaling investor uncertainty about true valuation. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Isomorphic Labs (Alphabet)	losing to	Alphabet fields its own physics-AI drug discovery unit, directly overlapping SandboxAQ's life sciences line as of 2026.
CrowdStrike	contesting	Named integration partner for AQtive Guard since April 2025, but could commoditize SandboxAQ's AI-SPM feature.
Palo Alto Networks	contesting	Integration partner for AQtive Guard since April 2025, positioned to absorb data-integration features.
Quantinuum	contesting	Named rival in post-quantum cryptography rankings as of May 2026.
PQShield	contesting	Oxford spinout competing directly in hardware-first PQC market, cited May 2026.
Cyera	losing to	Larger cybersecurity peer valued at 12 billion dollars via Series G, per July 2026 Caplight ranking.

Questions people ask

Is SandboxAQ profitable in 2026?: No public evidence of profitability exists. The Information reported Q1 2025 revenue of about 10 million dollars, with roughly 90 percent tied to a single Sergey Brin foundation contract, not diversified commercial sales, as of July 2025.
Who owns SandboxAQ?: SandboxAQ is privately held, spun out of Alphabet in March 2022. Google/Alphabet remains an investor alongside Nvidia, BNP Paribas, Ray Dalio's firm, and others from its April 2025 Series E round that valued it near 5.6 to 5.78 billion dollars.
Could AI replace SandboxAQ's technology?: SandboxAQ argues generic large language models cannot replace its physics-grounded Large Quantitative Models for molecular simulation or cryptographic risk detection, but it open-sourced its flagship 5.2 million molecule dataset in June 2025, weakening its own proprietary-data claim.
Who is SandboxAQ's biggest competitor?: In cybersecurity/post-quantum cryptography, named rivals include Quantinuum, PQShield, QuSecure, ISARA, and Post-Quantum, per a May 2026 industry ranking. In drug discovery, Alphabet's own Isomorphic Labs is a direct competitive threat.
How much is SandboxAQ worth?: Reuters-confirmed private valuation is 5.6 to 5.78 billion dollars as of the April 2025 Series E round. Some aggregators like Caplight claim a post-CHIPS valuation as high as 15.64 billion dollars, but this figure is unconfirmed by press reporting.
Did SandboxAQ get government funding?: Yes. On June 17, 2026, the U.S. Department of Commerce awarded SandboxAQ a 500 million dollar CHIPS Act R&D grant, with an unusual condition attaching a minority, non-voting government equity stake to the company.

Timeline

2026-07-01SandboxAQ's LQMs listed on Google Cloud Marketplace for broader AI-tool distribution
2026-06-17U.S. Commerce Department awards SandboxAQ 500 million dollar CHIPS Act grant with equity stake
2026-01SandboxAQ launches AQAffinity drug-potency prediction tool built on OpenFold3
2025-12-09SandboxAQ partners with U.S. Department of War/DoD CIO on post-quantum cryptography
2025-12-03SandboxAQ achieves FedRAMP Ready status, opening federal sales channel
2025-10SandboxAQ launches OpenCryptography.com public database of cryptographic risks
2025-07-16The Information reports Q1 2025 revenue of about 10 million dollars, 90 percent from Brin foundation
2025-06-18SandboxAQ releases 5.2 million synthetic 3D molecule dataset publicly
2025-04-21AQtive Guard AI-Security Posture Management platform goes generally available
2022-03-22SandboxAQ spun out of Alphabet as independent company

Revision history

29 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

American Airlines Group Wayfair Safe Superintelligence Inc.